AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes
NCT ID: NCT07336459
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-04-17
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention Trial Using Artificial Intelligence(AI) Diet Application for Management of Diet in Diabetes Patients
NCT06089655
Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
NCT06957093
Lifestyle Changes and Glycemic Control in T1D
NCT03864991
Mobile Health and Wearable Devices for Diabetes Complication Management
NCT07129148
Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control
NCT06151821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AI-Guided Multimodal Rehabilitation Program
AI-Guided Multimodal Rehabilitation Program
Digital Health: Mobile AI-based app with glucose tracking, exercise reminders, and fasting compliance monitoring Intermittent Fasting: 16:8 time-restricted feeding protocol, 5 days/week Resistance Training: 3 sessions/week (45 minutes), supervised + home-based program using elastic bands \& bodyweight
Standard Diabetes Care
Standard Diabetes Care
Usual pharmacological treatment + general lifestyle advice No structured AI, fasting, or exercise protocol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AI-Guided Multimodal Rehabilitation Program
Digital Health: Mobile AI-based app with glucose tracking, exercise reminders, and fasting compliance monitoring Intermittent Fasting: 16:8 time-restricted feeding protocol, 5 days/week Resistance Training: 3 sessions/week (45 minutes), supervised + home-based program using elastic bands \& bodyweight
Standard Diabetes Care
Usual pharmacological treatment + general lifestyle advice No structured AI, fasting, or exercise protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1c between 6.5% and 9.0%
* Sedentary or low physical activity levels
* BMI: 25-35 kg/m²
* Able to perform mild-to-moderate exercise
Exclusion Criteria
* not willing
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Superior University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Naveed Babur
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Superior University CRC
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PhDRSW/Batch-Fall23/2228
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.